Junshi Biosciences Announces Submission of a Marketing Authorization Application to the European Medicines Agency for Toripalimab

Shanghai Junshi Biosciences Co., Ltd. announced that the company has submitted a marketing authorization application to the European Medicines Agency for toripalimab for the treatment of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.